TMDX
Ticker
TransMedics Group Inc
Company
Devices
Industry
Healthcare
Sector
2016
+
2017
+
2018
+
2019
+
2020
+
2021
+
2022
+
2023
+
2024
+
2025
TTM
Revenue Growth YoY
23.8%69.4%81.3%8.6%18.0%208.8%158.5%82.7% 41.2%
Revenue Growth QoQ
Gross Margin
12.3%27.8%44.1%58.7%64.9%69.9%69.8%63.8%59.4% 60.3%
EBITDA Margin
-363.3%-257.6%-149.6%-120.2%-96.8%-124.3%-29.9%-8.5%13.0% 21.4%
Operating Margin
-370.2%-265.8%-155.5%-125.4%-102.9%-130.3%-33.6%-11.9%8.5% 16.9%
Profit Margin
-387.6%-271.0%-182.5%-142.1%-112.1%-146.1%-38.8%-10.4%8.0% 16.2%
FCF / EBITDA
113.4%118.0%135.6%114.3%123.8%86.1%206.5%802.3%-141.4% 99.4%